RTI Surgical Celebrates First Human Implantation of map3 Cellular Allogeneic Bone Graft
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
ALACHUA, Fla.--(BUSINESS WIRE)--RTI Surgical Inc. (RTI) (Nasdaq: RTIX), a global surgical implant company, is pleased to announce that the first human implantation of the company’s map3™ Cellular Allogeneic Bone Graft implant was completed last week.
Help employers find you! Check out all the jobs and post your resume.
ALACHUA, Fla.--(BUSINESS WIRE)--RTI Surgical Inc. (RTI) (Nasdaq: RTIX), a global surgical implant company, is pleased to announce that the first human implantation of the company’s map3™ Cellular Allogeneic Bone Graft implant was completed last week.
Help employers find you! Check out all the jobs and post your resume.